Qingdao Hi-Tech Moulds & Plastics Technology (301022)

Search documents
海泰科(301022) - 董事会对独董独立性评估的专项意见
2025-04-23 08:52
经核查独立董事丁乃秀女士、刘树国先生、张美萍女士的任职经历以及签署 的相关自查文件,上述人员未在公司担任除独立董事以外的任何职务,也未在公 司主要股东公司担任任何职务,与公司以及主要股东之间不存在利害关系或其他 可能妨碍其进行独立客观判断的关系,不存在影响独立董事独立性的情况,因此, 公司独立董事符合《上市公司独立董事管理办法》、《深圳证券交易所上市公司自 律监管指引第 2 号——创业板上市公司规范运作》中对独立董事独立性的相关要 求。 青岛海泰科模塑科技股份有限公司董事会 青岛海泰科模塑科技股份有限公司 董事会对独立董事独立性自查情况的专项意见 根据《上市公司独立董事管理办法》、《深圳证券交易所上市公司自律监管指 引第 2 号——创业板上市公司规范运作》的规定,青岛海泰科模塑科技股份有限 公司(以下简称"公司")第二届董事会独立董事对自身独立性情况进行了自查 并出具了《独立董事独立性自查情况表》,公司于 2025 年 4 月 23 日召开第二届 董事会第二十九次会议,审议通过了《关于独立董事独立性自查情况的专项意见 的议案》,公司董事会就独立董事丁乃秀女士、刘树国先生、张美萍女士的独立 性情况进行评估并出具 ...
海泰科(301022) - 独立董事2024年度述职报告(丁乃秀)
2025-04-23 08:52
青岛海泰科模塑科技股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表: 本人(丁乃秀)作为青岛海泰科模塑科技股份有限公司(以下简称"公司")的第二届董 事会独立董事,根据《公司法》《上市公司独立董事管理办法》《深圳证券交易所创业板股票上 市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法 律法规、规范性文件以及《公司章程》《独立董事工作制度》的规定,诚实、勤勉、独立地履 行职责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对相关事项发表意见, 同时充分发挥独立董事及所担任的专门委员会委员的作用,切实维护公司和股东特别是中小 股东的合法权益。现就本人 2024 年度的履职情况报告如下: 一、基本情况 (一)个人简历 丁乃秀女士,1975 年出生,中国国籍,博士研究生学历,材料加工工程专业,青岛科技大 学教授,无境外永久居留权。2005 年 3 月至 2007 年 12 月,任青岛科技大学高分子材料教师。 2007 年 12 月至 2014 年 12 月,任青岛科技大学高分子材料副教授;2015 年 1 月至今,任青 岛科技大学高分子材料教授;201 ...
海泰科(301022) - 独立董事2024年度述职报告(刘树国)
2025-04-23 08:52
青岛海泰科模塑科技股份有限公司 独立董事 2024 年度述职报告 各位股东及股东代表: 本人(刘树国)作为青岛海泰科模塑科技股份有限公司(以下简称"公司")的第二届 董事会独立董事,根据《公司法》《上市公司独立董事管理办法》《深圳证券交易所创业板股 票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运 作》等法律法规、规范性文件以及《公司章程》《独立董事工作制度》的规定,诚实、勤勉、 独立地履行职责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对相关事 项发表意见,同时充分发挥独立董事及所担任的专门委员会委员的作用,切实维护公司和股 东特别是中小股东的合法权益。现就本人 2024 年度的履职情况报告如下: 一、基本情况 (一)个人简历 刘树国先生,1979 年出生,中国国籍,本科学历,会计学专业,中国注册会计师、注册 资产评估师,无境外永久居留权。2002 年 7 月至 2005 年 3 月,任南车四方机车车辆股份有 限公司材料会计;2005 年 3 月至 2008 年 3 月,任青岛四方川崎车辆技术有限公司财务经 理;2008 年 3 月至 2015 年 7 月,历 ...
海泰科(301022) - 2024 Q4 - 年度财报
2025-04-23 08:30
Financial Performance - The company's operating revenue for 2024 reached ¥678,851,952.86, representing an increase of 18.59% compared to ¥572,438,348.90 in 2023[17]. - The net profit attributable to shareholders decreased by 32.34% to ¥15,756,018.03 in 2024 from ¥23,286,753.69 in 2023[17]. - The net profit after deducting non-recurring gains and losses fell by 51.31% to ¥8,162,379.05 in 2024 from ¥16,763,649.22 in 2023[17]. - The net cash flow from operating activities improved significantly to ¥86,249,206.64 in 2024, a 301.16% increase from -¥42,876,432.64 in 2023[17]. - The total assets at the end of 2024 were ¥1,921,788,603.80, reflecting a 3.86% increase from ¥1,850,347,745.42 at the end of 2023[17]. - The net assets attributable to shareholders increased by 3.80% to ¥1,044,372,336.21 in 2024 from ¥1,006,099,194.22 in 2023[17]. - The company reported a significant decline in basic earnings per share, which fell by 32.87% to ¥0.1879 in 2024 from ¥0.2799 in 2023[17]. - The company achieved a research and development investment of 28.33 million yuan in 2024, accounting for 4.17% of its revenue[74]. - The company reported a net profit attributable to shareholders of 1,575.60 million yuan in 2024, a decrease of 32.34% compared to the previous year[84]. - The company reported a total revenue of approximately 591.43 million for its injection mold business, with a net profit of around 22.34 million[142]. Dividend and Shareholder Information - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 84,757,008 shares as of December 31, 2024[4]. - The company implemented a cash dividend plan for 2023, distributing 21.63 million yuan to shareholders, which accounts for 92.89% of the 2023 net profit of 23.29 million yuan[91]. - The total shares held by the board members at the end of the reporting period increased to 43,383 shares, reflecting a change due to stock incentives[182]. - The company held a temporary shareholders' meeting on January 11, 2024, with a participation rate of 63.24%, approving several amendments to the company's articles of association and rules[180]. - The annual shareholders' meeting on May 16, 2024, had a participation rate of 62.50%, where the 2023 annual report and financial statements were approved[180]. Market and Industry Trends - In 2024, China's automotive production and sales reached 31.28 million and 31.44 million units, respectively, representing year-on-year growth of 3.7% and 4.5%[29]. - Passenger vehicle production and sales were 27.48 million and 27.56 million units, with year-on-year increases of 5.2% and 5.8%[29]. - New energy vehicle sales surpassed 10 million units for the first time, accounting for over 40% of total sales, marking a new phase of high-quality development[29]. - The automotive injection mold market in China has exceeded 50 billion RMB, with expectations for continued rapid growth in the coming years[36]. - The automotive injection mold industry is benefiting from the push for lightweight vehicles, with a projected 40% reduction in vehicle weight by 2030 compared to 2015[37]. - The demand for high-quality, low-cost, and rapid production in the automotive sector is driving the injection mold industry towards larger, more complex, and economical solutions[40]. - The automotive industry's shift towards personalization and high-end features is increasing the demand for diverse interior and exterior components, impacting mold requirements[68]. Research and Development - The company has obtained 26 invention patents and 72 utility model patents, showcasing its strong innovation capabilities in injection mold technology[74]. - The company focuses on product and technology innovation, with a robust R&D management system and collaboration with academic institutions to enhance innovation capabilities[66]. - The company is actively pursuing technological advancements in injection molding to enhance product offerings and operational efficiency[102]. - The company has completed multiple projects related to injection molding technology, with products now available in the automotive parts market, enhancing its core competitiveness[104]. - R&D personnel increased from 156 in 2023 to 164 in 2024, representing a growth of 5.13%[105]. Customer Base and Sales - The company has formed a large and stable customer base, supplying molds to renowned automotive interior and exterior parts companies such as Yanfeng, IAC, and Magna[45]. - The company has established a strong customer base, supplying molds to renowned automotive brands such as General Motors, Volkswagen, and BMW[51]. - The company sold 654 sets of automotive molds in 2024, a 33.74% increase from 489 sets in 2023, attributed to improved inventory turnover[95]. - New orders for injection molds reached 852 million yuan, a year-on-year increase of 26.97%, with total orders on hand amounting to 938 million yuan, up 22.57%[84]. Financial Management and Investments - The company has established a comprehensive supplier management system, ensuring stable relationships with key suppliers for raw material procurement[61]. - The company has implemented a refined management strategy to enhance efficiency, including upgrades to the standard parts library and the launch of a knowledge management platform to improve organizational capabilities[89]. - The company has established a foreign exchange management system to control trading risks associated with foreign exchange hedging[121]. - The company has approved the use of idle raised funds for operational activities, ensuring that the fundraising plan is implemented normally[134]. - The company has not engaged in speculative derivative investments during the reporting period[122]. Governance and Compliance - The company has established a governance structure that complies with relevant laws and regulations, ensuring the protection of shareholder interests[165]. - The board of directors consists of 7 members, including 3 independent directors, meeting legal requirements for composition[167]. - The company maintains complete independence in assets, personnel, finance, and operations from its controlling shareholders, ensuring no interference in decision-making[174]. - The company has implemented strict compliance with relevant laws and regulations during the review of significant proposals[200]. - The company actively promotes investor relations and ensures timely and accurate information disclosure to all shareholders[172].
海泰科(301022) - 2025 Q1 - 季度财报
2025-04-23 08:30
Financial Performance - The company's revenue for Q1 2025 reached ¥192,373,169.29, representing a 37.20% increase compared to ¥140,218,322.92 in the same period last year[5] - Net profit attributable to shareholders surged to ¥13,919,563.22, a remarkable increase of 5,738.82% from ¥238,396.91 in the previous year[5] - The net profit excluding non-recurring gains and losses was ¥12,553,880.12, up 652.95% from a loss of ¥2,270,347.09 in the same period last year[5] - Basic earnings per share rose to ¥0.1642, reflecting a staggering increase of 5,562.07% from ¥0.0029 in the same period last year[5] - Total operating revenue for the current period reached ¥192,373,169.29, a significant increase from ¥140,218,322.92 in the previous period, representing a growth of approximately 37.2%[25] - Net profit for the current period was ¥13,919,563.22, a substantial rise from ¥238,396.91 in the previous period, reflecting a growth of over 5,700%[26] - Basic and diluted earnings per share for the current period were both ¥0.1642, compared to ¥0.0029 in the previous period, marking an increase of approximately 5,572.4%[27] - The total comprehensive income for the current period was ¥14,263,426.46, compared to a loss of ¥4,213,534.94 in the previous period[27] Assets and Liabilities - The company's total assets increased by 4.72% to ¥2,012,495,393.23 from ¥1,921,788,603.80 at the end of the previous year[5] - The company's total assets as of March 31, 2025, amount to CNY 2,012,495,393.23, an increase from CNY 1,921,788,603.80 at the beginning of the period[21][23] - Current assets total CNY 1,307,109,141.17, up from CNY 1,241,500,468.98 at the start of the period[21] - The company's total liabilities are CNY 951,919,455.63, compared to CNY 877,416,267.59 at the beginning of the period[23] Cash Flow - Cash flow from operating activities showed a significant decline, with a net outflow of ¥20,445,893.41 compared to an outflow of ¥3,069,430.48 in the previous year, marking a decrease of 566.11%[5] - Net cash flow from operating activities was negative at ¥20,445,893.41, worsening from a negative cash flow of ¥3,069,430.48 in the prior period[28] - Cash flow from investing activities showed a net outflow of ¥34,753,788.90, a decline from a net inflow of ¥6,163,921.24 in the previous period[29] - Cash flow from financing activities generated a net inflow of ¥67,905,431.00, significantly higher than the previous period's inflow of ¥14,063,151.43[29] Shareholder Information - The total number of common shareholders at the end of the reporting period is 10,458[17] - The top 10 shareholders hold a combined 75.77% of the shares, with Sun Wenqiang holding 30.78% and Wang Jixue holding 17.39%[17] Government Support and Expenses - The company reported a 208.60% increase in tax refunds received, amounting to ¥5,992,403.10, compared to ¥1,941,808.95 in the previous year[16] - The company incurred a financial expense of -¥2,348,089.75, a decrease of 118.97% from ¥12,377,197.12 in the previous year, primarily due to foreign exchange gains[13] - The company received government subsidies amounting to ¥1,024,432.75, which is a 153.90% increase from ¥403,478.11 in the previous year[13] - The company reported a tax expense of ¥-12,891.84, a decrease from a tax expense of ¥-2,119,115.36 in the prior period[26] Investment Plans - The company plans to invest CNY 40 million in its wholly-owned subsidiary in Thailand as part of its overseas expansion strategy[19] - The company is currently undergoing the approval process for its overseas investment with relevant domestic authorities[19] Inventory and Cash Balance - The company has a cash balance of CNY 135,784,292.24, up from CNY 122,291,960.26 at the beginning of the period[21] - The inventory balance is CNY 556,448,455.89, an increase from CNY 533,621,172.09[22] - The ending cash and cash equivalents balance was ¥119,887,168.91, up from ¥117,070,895.18 at the end of the previous period[29]
海泰科(301022) - 2024年度内部控制自我评价报告
2025-04-23 08:28
青岛海泰科模塑科技股份有限公司 2024 年度内部控制自我评价报告 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管 要求(以下简称"企业内部控制规范体系"),结合青岛海泰科模塑科技股份有 限公司(以下简称"公司"或"本公司")内部控制制度和评价办法,在内部控 制日常监督和专项监督的基础上,我们对公司截至 2024 年 12 月 31 日(内部控 制评价报告基准日)的内部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定,建立健全和有效实施内部控制,评价 其有效性,并如实披露内部控制评价报告是公司董事会的责任。监事会对董事 会建立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运 行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在 任何虚假记载、误导性陈述或重大遗漏,并对报告内容的真实性、准确性和完 整性承担个别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告 及相关信息真实完整,提高经营效率和效果,促进实现发展战略。由于内部控 制存在的固有局限性,故仅能为实现上述目标提供合理保证。此外,由于经营 情况的变化可能 ...
海泰科(301022) - 2024年年度报告披露提示性公告
2025-04-23 08:28
特此公告。 青岛海泰科模塑科技股份有限公司董事会 2025 年 4 月 24 日 | 证券代码:301022 | 证券简称:海泰科 | 公告编号:2025-038 | | --- | --- | --- | | 债券代码:123200 | 债券简称:海泰转债 | | 青岛海泰科模塑科技股份有限公司 2024 年年度报告披露提示性公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 青岛海泰科模塑科技股份有限公司《2024 年年度报告》及《2024 年年度报 告摘要》于 2025 年 4 月 24 日在中国证券监督管理委员会指定的创业板信息披露 网站巨潮资讯网(www.cninfo.com.cn)上披露,敬请投资者注意查阅。 1 ...
海泰科(301022) - 关于提请股东大会授权董事会办理小额快速融资相关事宜的公告
2025-04-23 08:28
| 证券代码:301022 | 证券简称:海泰科 | 公告编号:2025-050 | | --- | --- | --- | | 债券代码:123200 | 债券简称:海泰转债 | | 青岛海泰科模塑科技股份有限公司 关于提请股东大会授权董事会办理小额快速融资相关事宜的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整,没有虚假 记载、误导性陈述或重大遗漏。 青岛海泰科模塑科技股份有限公司(以下简称"公司")于 2025 年 4 月 23 日 召开了第二届董事会第二十九次会议和第二届监事会第二十四次会议,审议通过 了《关于提请股东大会授权董事会办理小额快速融资相关事宜的议案》。根据中国 证券监督管理委员会《上市公司证券发行注册管理办法》(以下简称"《注册管理办 法》")等相关规定,公司董事会提请股东大会授权董事会向特定对象发行融资总额 不超过人民币 3 亿元且不超过最近一年末净资产 20%的股票,授权期限为自公司 2024 年度股东大会审议通过之日起至公司 2025 年度股东大会召开之日止。本次授 权事宜包括以下内容: 1、确认公司是否符合以简易程序向特定对象发行股票(以下简称"小额快速 融资") ...
海泰科(301022) - 2024年度监事会工作报告
2025-04-23 08:27
2024 年度,青岛海泰科模塑科技股份有限公司(以下简称"公司")监事会 全体成员严格按照《中华人民共和国公司法》(以下简称"《公司法》")、《中华人 民共和国证券法》(以下简称"《证券法》")、《深圳证券交易所创业板股票上市规 则》、《深圳证券交易所上市公司自律监管指引第 2 号—创业板上市公司规范运 作》等法律、法规、规范性文件以及《公司章程》、《监事会议事规则》等相关规 定和要求,认真履行了自身职责,依法独立行使监事会的监督权,促进公司规范 运作,维护公司、股东及员工的合法权益。 监事会成员列席了报告期内部分董事会和所有股东会,对公司经营活动、财 务状况、重大决策、股东会召开程序以及董事、高级管理人员履行职责情况等方 面实施了有效监督和检查。现将 2024 年监事工作情况汇报如下: 青岛海泰科模塑科技股份有限公司 2024 年度监事会工作报告 一、2024 年监事会召开情况 报告期内,公司监事会召开会议 7 次,3 名监事均亲自出席会议,无缺席会 议的情况,本年度会议的通知、召集、召开和表决程序均符合有关法律、法规和 《公司章程》的有关规定。具体情况和决议内容如下: 1、公司于 2024 年 1 月 2 ...
海泰科(301022) - 2024年度财务决算报告
2025-04-23 08:27
青岛海泰科模塑科技股份有限公司 2024年度财务决算报告 青岛海泰科模塑科技股份有限公司2024年度财务报表按照《企业会计准则》的规定编制,在所 有重大方面公允反映了公司2024年12月31日的财务状况以及2024年度的经营成果和现金流量,并已 经中兴华会计师事务所(特殊普通合伙)审计,出具了中兴华审字(2025)第030041号标准无保留 意见的审计报告,现将决算报告情况报告如下: | | 2024 年 | 2023 年 | | 本年比 上年增 | 2022 年 | | | --- | --- | --- | --- | --- | --- | --- | | | | | | 减 | | | | | | 调整前 | 调整后 | 调整后 | 调整前 | 调整后 | | 营业收 | 678,851,952.86 | 572,438,348.90 | 572,438,348.90 | 18.59% | 500,318,854.64 | 500,318,854.64 | | 入(元) | | | | | | | | 归属于 | | | | | | | | 上市公 | | | | | | | | 司股东 | 15,7 ...